Our primary strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. In addition to building an efficient in-house clinical development organization with regulatory and data management capabilities, Spectrum has e…
Our primary strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. In addition to building an efficient in-house clinical development organization with regulatory and data management capabilities, Spectrum has established a commercial infrastructure for itsmarketed products. We have two oncology products on the market, one for low-grade or follicular non-Hodgkin's lymphoma and one for advanced metastatic colorectal cancer, as well as two drugs in late stage development: apaziquone and belinostat, along with a diverse pipeline. We also leverage the expertise of our worldwide partners to assist in the execution of our strategy. Our passion to identify, develop and deliver important options for people suffering from cancer is behind every action we take. At Spectrum, we are committed to excellence and strive to make a difference in the lives of patients every day. The Key is our People Collectively, the members of our team have relevant experience in both the development and marketing of oncology drugs and the growth of profitable business ventures. Our Goal is to Bring Quality Drugs to Patients Spectrum Pharmaceuticals actively seeks to leverage its extensive contacts in the pharmaceutical and scientific communities to identify potentially important drug candidates that require further clinical development. Once we identify these candidates, we rapidly assess preclinical and clinical data, and the commercialization potential of candidates. Then through both in-licensing and co-development partnerships, we provide the expertise and neccesary funding to bring the most promising products through the complex development process to market. In order to maximize the commercial potential of our current and future drugs, Spectrum has assembled a distinguished Commercial Team that was recruited from the top sales performers in the oncology specialty arena, and who are dedicated to bringing important, quality treatments to cancer patients.
Team (2)
Sectors Spectrum Pharmaceuticals, Inc. (NasdaqGS:SPPI) serves:
Life Sciences
Join Axial's Private M&A Platform
Spectrum Pharmaceuticals, Inc. (NasdaqGS:SPPI) connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
